Evidence map›Paper›PMID 33498191›Full record

ArticleAntibiotics (Basel, Switzerland)2021

The Resistance to Host Antimicrobial Peptides in Infections Caused by Daptomycin-Resistant

Md Saruar Bhuiyan, Jhih-Hang Jiang, Xenia Kostoulias, Ravali Theegala, Graham J Lieschke, Anton Y Peleg

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Combination of Amphiphilic Cyclic Peptide [RAntibiotics (Basel, Switzerland) · 2022
    Article
  6. Zebrafish: An Attractive Model to StudyPharmaceuticals (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Md Saruar BhuiyanInfection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, VIC 3800, Australia.ORCID 0000-0002-4692-2567
Jhih-Hang JiangInfection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, VIC 3800, Australia.ORCID 0000-0002-1543-1634
Xenia KostouliasInfection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, VIC 3800, Australia.
Ravali TheegalaInfection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, VIC 3800, Australia.
Graham J LieschkeAustralian Regenerative Medicine Institute, Monash University, Clayton, VIC 3800, Australia.ORCID 0000-0003-0325-798X
Anton Y PelegInfection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, VIC 3800, Australia.ORCID 0000-0002-2296-2126
Australian Regenerative Medicine Institute · AU

Funding

National Health and Medical Research Council APP1144303
6 · The paper itself

Abstract

Daptomycin is an important antibiotic for the treatment of infections caused by

Indexed as

antimicrobial peptidesdaptomycinpersistent infectionS. aureus

Identifiers

PMID33498191
PMCPMC7908987
OpenAlexW3125980070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.